会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • 성장촉진추출물 및 이를 함유하는 약학적 제제
    • 生长促进提取物和含有其的药物制剂
    • KR1020030030337A
    • 2003-04-18
    • KR1020010062209
    • 2001-10-09
    • 학교법인 경희학원윤석호
    • 김선여석경호조금호박주영임강현박선영부영민이동환이강진조택상
    • A61K36/254A61K36/804A61K36/8945A61P19/00
    • PURPOSE: A pharmaceutical formulation containing, as an effective ingredient, an extract for promoting the growth of a mammal extracted from natural drugs such as Acanthopanax Senticosus(Rupr. et Maxim.) Harms, etc. is provided. The formulation has no toxicity and excellent growth promotion activity and is thus effectively used in treatment and prevention of homunculus, dwarfism and failure to thrive syndrome of children and infants. CONSTITUTION: The pharmaceutical formulation contains a growth promotion extract and a pharmaceutically acceptable excipient. The growth promotion extract is obtained from 10 to 99% by weight of Acanthopanax Senticosus, 0.1 to 60% by weight of Rehmanniae Radix Preparata, 0.1 to 60% by weight of Dioscoreae Rhizoma, 0.1 to 60% by weight of Corni Fructus, 0.1 to 60% by weight of Poria cocos, 0.1 to 60% by weight of Cervi cornu and 0.1 to 60% by weight of Ginseng Radix.
    • 目的:提供含有作为有效成分的用于促进从天然药物如刺五加(Rupr。et.Mac。)Harms等提取的哺乳动物生长的提取物的药物制剂。 该制剂没有毒性和优良的生长促进活性,因此有效地用于治疗和预防儿童,侏儒症以及未成熟的儿童和婴儿综合征。 构成:药物制剂含有生长促进提取物和药学上可接受的赋形剂。 生长促进提取物以10〜99重量%的刺五加,0.1〜60重量%的地黄,0.1〜60重量%的薯is,0.1〜60重量%的康乃馨,0.1〜 60%重量的茯苓,0.1至60%的Cervi cornu和0.1至60%的人参。
    • 4. 发明授权
    • 성장촉진추출물 및 이를 함유하는 약학적 제제
    • 성장촉진추출물및이를함유하는약학적제제
    • KR100404455B1
    • 2003-11-03
    • KR1020010062209
    • 2001-10-09
    • 학교법인 경희학원윤석호
    • 김선여석경호조금호박주영임강현박선영부영민이동환이강진조택상
    • A61K36/254A61K36/804A61K36/8945A61P19/00
    • PURPOSE: A pharmaceutical formulation containing, as an effective ingredient, an extract for promoting the growth of a mammal extracted from natural drugs such as Acanthopanax Senticosus(Rupr. et Maxim.) Harms, etc. is provided. The formulation has no toxicity and excellent growth promotion activity and is thus effectively used in treatment and prevention of homunculus, dwarfism and failure to thrive syndrome of children and infants. CONSTITUTION: The pharmaceutical formulation contains a growth promotion extract and a pharmaceutically acceptable excipient. The growth promotion extract is obtained from 10 to 99% by weight of Acanthopanax Senticosus, 0.1 to 60% by weight of Rehmanniae Radix Preparata, 0.1 to 60% by weight of Dioscoreae Rhizoma, 0.1 to 60% by weight of Corni Fructus, 0.1 to 60% by weight of Poria cocos, 0.1 to 60% by weight of Cervi cornu and 0.1 to 60% by weight of Ginseng Radix.
    • 目的:提供一种药物制剂,其含有作为有效成分的用于促进从刺五加(Acanthopanax Senticosus(Rupr。Maxim。)Harms等天然药物提取的哺乳动物的生长的提取物)。 该制剂没有毒性和优异的生长促进活性,因此被有效地用于治疗和预防儿童和婴儿的矮人,侏儒症和不能发育不良的综合症。 构成:药物制剂含有生长促进提取物和药学上可接受的赋形剂。 所述生长促进提取物由刺五加10〜99重量%,地黄0.1〜​​60重量%,山药0.1〜60重量%,山茱萸0.1〜60重量%,0.1〜 60重量%的茯苓,0.1至60重量%的Cervi cornu和0.1至60重量%的人参根。